Why we're doing this
Material sold as SR-17018 in unregulated channels can contain other compounds — including significantly more dangerous ones such as nitazenes or fentanyl analogs. The orphine family alone now includes a dozen compounds, several of which look chemically similar enough that low-resolution analysis can confuse them. Some vendors are ethical and competent; others are neither. The only way to tell the difference is to test.
How the program works
Acquire the sample
We anonymously purchase material sold as SR-17018 from public-facing vendors, marketplaces, and storefronts. Vendor and listing details are recorded for the public report.
Chain of custody
On arrival, the package is photographed sealed, weighed, and assigned a unique batch ID. From that point, every transfer is logged.
Analytical workup
Samples are sent to an accredited laboratory for LC–MS/MS confirmation, quantitation against a certified reference standard, and a multi-target adulterant panel.
Independent review
Raw data — chromatograms, mass spectra, calibration curves — is reviewed by a second analyst before publication.
Public report
Each test is published as a full report on this site, including methodology, vendor, batch, and full data files. No paywall.
What's in the panel
| Test | What it confirms |
|---|---|
| Identity | LC–MS/MS confirmation against certified SR-17018 reference standard |
| Purity / quantitation | % w/w of SR-17018 in the supplied material |
| Orphine-analog screen | Brorphine, SR-14968, chlorphine and family |
| High-potency opioid screen | Fentanyl analogs, nitazenes (etonitazene, isotonitazene, metonitazene, protonitazene, etc.) |
| Common drug-of-abuse screen | Morphine, oxycodone, methadone, tramadol, methamphetamine |
| Heavy metals | Pb, As, Cd, Hg by ICP-MS |
| Residual solvents | Per ICH Q3C class 1–3 limits |
| Moisture / appearance | Karl Fischer titration; visual record |
We will revise and expand the panel as the orphine family and the unregulated supply evolve. Methodology changes will be documented in the per-batch reports.
User-submitted samples
The goal is harm reduction at scale: if a vendor is shipping adulterated or misidentified product, that fact reaches the next prospective buyer before they ingest it.
What we will and won't do with samples
- We will analyze, document, and publish results.
- We will not return samples after testing (they are consumed during analytical workup).
- We will not share submitter information with vendors, law enforcement, or any third party except as required by law.
- We will not analyze any sample whose accompanying documentation suggests an unlawful purpose unrelated to harm reduction.
How results are published
- Every test gets a public, permanent report page on this site.
- Reports include vendor, listing URL, batch, photos, full chromatogram and mass spectrum, and analyst notes.
- Raw data files are downloadable for independent re-analysis.
- We do not redact vendor identity. The point is accountability.
- We accept and publish vendor responses alongside reports when they engage substantively.
Ethics, privacy, legality
- Harm reduction frame. We do not encourage SR-17018 use. We document what is being sold so that people who would have used it anyway can do so with better information about what is actually in the package.
- Submitter privacy. No identifying data is retained beyond what is needed to operate the mail intake. Submitter records are kept separate from published reports.
- Legality of testing. Analytical testing of small reference quantities of controlled or scheduled substances by accredited laboratories is a long-standing forensic and regulatory practice. Our lab partners hold the appropriate registrations.
- Conflicts of interest. The program does not accept funding from vendors. We do not sell SR-17018, link to vendor purchase pages, or participate in affiliate programs.
Stay informed
Get notified when the program goes live
We'll publish the launch on the homepage and announce the first batch of vendor tests. No spam, no marketing.
We'll wire this up to a real form provider before launch. For now it's a placeholder.